Atazanavir 300 mg + Ritonavir 100 mg
This combination pairs a protease inhibitor with a pharmacokinetic enhancer to improve drug exposure and therapeutic effectiveness in the management of HIV-1 infection, in line with established treatment guidelines.
Product Details
Therapeutic Class
Protease Inhibitor (Atazanavir)
Pharmacokinetic Enhancer (Ritonavir)
Indication
Treatment of HIV-1 infection in adults and adolescents as part of combination antiretroviral therapy (ART), in accordance with WHO and NACO recommendations.
Dosage & Administration
Atazanavir 300 mg boosted with Ritonavir 100 mg once daily, or as prescribed by a healthcare professional.
To be used strictly as part of a combination ART regimen.
Storage
Store below 30°C in a dry place, protected from light and moisture.
Disclaimer
Prescription medicine. To be used only under medical supervision and in line with WHO and NACO treatment guidelines.
Pack Size
30 Tablets
Atazanavir 300 mg + Ritonavir 100 mg
This combination pairs a protease inhibitor with a pharmacokinetic enhancer to improve drug exposure and therapeutic effectiveness in the management of HIV-1 infection, in line with established treatment guidelines.
Product Details
Therapeutic Class
Protease Inhibitor (Atazanavir)
Pharmacokinetic Enhancer (Ritonavir)
Indication
Treatment of HIV-1 infection in adults and adolescents as part of combination antiretroviral therapy (ART), in accordance with WHO and NACO recommendations.
Dosage & Administration
Atazanavir 300 mg boosted with Ritonavir 100 mg once daily, or as prescribed by a healthcare professional.
To be used strictly as part of a combination ART regimen.
Storage
Store below 30°C in a dry place, protected from light and moisture.
Disclaimer
Prescription medicine. To be used only under medical supervision and in line with WHO and NACO treatment guidelines.
Pack Size
30 Tablets
Atazanavir 300 mg + Ritonavir 100 mg
This combination pairs a protease inhibitor with a pharmacokinetic enhancer to improve drug exposure and therapeutic effectiveness in the management of HIV-1 infection, in line with established treatment guidelines.
Product Details
Therapeutic Class
Protease Inhibitor (Atazanavir)
Pharmacokinetic Enhancer (Ritonavir)
Indication
Treatment of HIV-1 infection in adults and adolescents as part of combination antiretroviral therapy (ART), in accordance with WHO and NACO recommendations.
Dosage & Administration
Atazanavir 300 mg boosted with Ritonavir 100 mg once daily, or as prescribed by a healthcare professional.
To be used strictly as part of a combination ART regimen.
Storage
Store below 30°C in a dry place, protected from light and moisture.
Disclaimer
Prescription medicine. To be used only under medical supervision and in line with WHO and NACO treatment guidelines.
Pack Size
30 Tablets